A new analysis of over 18,000 cancer cases shows that obese patients may respond better to immunotherapy treatments, but many questions remain.

Recent study indicates that VDAC2 can make liver cancer cells more susceptible to cell death.

MIT researchers found a way to measure cell density quickly and accurately — measuring up to 30,000 cells in a single hour. They also showed density changes could be used to make useful predictions, including whether T cells have become activated to kill tumors or whether tumor cells are susceptible to a specific drug.

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists. Although the research has so far only been conducted in cell lines and mice, the team is seeking funding to begin clinical trials in patients shortly.